10-12 September 2018 //  Lancaster Royal Hotel, London


Patricia Zillox

Dr Patricia Zillox

Chief Drug Development Officer , Foundation Fighting Blindness
PATRICIA ZILLIOX, PH.D., is currently the Chief Drug Development Officer of the Clinical Research Institute, a division of the Foundation Fighting Blindness.  From late 2008 until May 2011, Patricia was Senior Director of Clinical Development at Alcon Laboratories, where she had global accountability for planning, development, execution, and management of pharmaceutical clinical programs in areas of eye diseases such as glaucoma, allergy, dry eye, infectious disease of the eye, and diseases of the retina, in particular dry AMD and wet AMD. One of the key accomplishments of her group under her leadership was the implementation and completion of the natural history clinical study of Geographic Atrophy progression (GAP study). Previously, Patricia was based in Paris, France where she was responsible for conduct and execution of clinical trials in ophthalmology across Europe for Alcon as well. Patricia Received a PharmD degree and a PhD from the University Louis Pasteur in Strasbourg France. Patricia also serves as Vice President of the French-American Chamber of Commerce (FACC) in Dallas.

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad